Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 35,050 shares at $45.01 ($1.6M) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Seasonal sale ($1.6M) by Senior Vice President — this insider has traded ABT in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 3,055 | $138K | 8.7% |
| 2 | $45.01 | 3,055 | $138K | 8.7% |
| 3 | $45.02 | 10,100 | $455K | 28.7% |
| 4 | $45.02 | 10,100 | $455K | 28.7% |
| 5 | $45.46 | 8,740 | $397K | 25.1% |
| Total | $45.13 avg | 35,050 |
| $1.6M |
| 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |